Bioservo Technologies AB Year-End Report 2022
Carbonhand ready for launch, but delay and postponed orders weigh on the quarter. Fourth quarter in figures · Net sales of SEK 1.3 M (2.3) · EBITDA of SEK -15.5 M (-7.5) · EBIT of SEK -16.0 M (-8.5) · Earnings for the period amounted to SEK -15.9 M (-8.5) · Earnings per share before and after dilution amounted to SEK -0.56 (-0.45) · Cash flow from operating activities for the period amounted to SEK -13.5 M (-8.5) Year End in figures · Net sales of SEK 9.6 M (7.1) · EBITDA of SEK -47.6 M (-30.5) · EBIT of SEK -50,5 M (-34.7) · Earnings for the period